Baird’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$128M Buy
1,270,921
+8,360
+0.7% +$850K 1.31% 6
2014
Q4
$132M Buy
1,262,561
+224,027
+22% +$23.6M 1.41% 3
2014
Q3
$111M Sell
1,038,534
-25,574
-2% -$2.65M 1.55% 3
2014
Q2
$111M Sell
1,064,108
-26,198
-2% -$2.65M 1.56% 3
2014
Q1
$107M Buy
1,090,306
+4,922
+0.5% +$456K 1.55% 2
2013
Q4
$99.4M Buy
1,085,384
+13,207
+1% +$1.22M 1.71% 4
2013
Q3
$92.9M Sell
1,072,177
-18,628
-2% -$1.67M 1.73% 3
2013
Q2
$93.7M Buy
+1,090,805
New +$92.6M 1.86% 2

Other funds holding JNJ

Baird's JNJ Position: Q1 2015 in Review

Baird increased its Johnson & Johnson (JNJ) stake by 0.66% in Q1 2015, buying an estimated $850K and bringing the position to 1,270,921 shares worth $128M. The position accounts for 1.31% of the portfolio, ranked #6.

Baird first reported a position in JNJ in Q2 2013 and has held it in 8 quarters since. The position peaked at $132M in Q4 2014. 2,101 funds tracked by Wall St. Rank hold JNJ as of Q1 2015.

  • Baird held 1,270,921 shares of Johnson & Johnson worth $128M as of Q1 2015.
  • Baird bought 8,360 Johnson & Johnson shares in Q1 2015, an estimated $850K.
  • Johnson & Johnson made up 1.31% of Baird's portfolio in Q1 2015, its #6 holding.
  • Baird first reported a position in Johnson & Johnson in Q2 2013 and has held it in 8 quarters since.
  • Baird's Johnson & Johnson position peaked at $132M in Q4 2014.
  • 2,101 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.